UCSF Expert: Pfizer COVID Antiviral Pill Would Be A Game ChangerPfizer's Friday announcement that its experimental antiviral pill for COVID-19 cut rates of hospitalization and death by nearly 90% in high-risk adults could be a game changer in the treatment of the virus. At least that was initial opinion of UCSF Professor of Medicine and Infections Disease Dr. Monica Gandhi.
CDC Recommends Pfizer COVID Vaccine For Children 5-11 Years OldThe CDC issued formal recommendations Tuesday for children as young as 5 years old to get vaccinated against COVID-19, clearing the final regulatory hurdle for younger kids to start receiving Pfizer's vaccine this week. 
FDA Authorizes Pfizer's COVID-19 Vaccine for Kids as Young as 5The Food and Drug Administration on Friday authorized a smaller dose of Pfizer's COVID-19 vaccine for children ages 5 to 11, a critical step for the more than 28 million children that may soon be eligible.
Bay Area Health Experts Weigh In After FDA Advisers Back Pfizer COVID-19 Vaccine For Kids 5 To 11Pfizer's request to roll out COVID-19 vaccines for Americans as young as 5 years old cleared a key regulatory hurdle Tuesday, after a panel of the Food and Drug Administration's outside vaccine advisers voted by a majority to back Pfizer's request.
Pfizer Scientist Testifies Against Holmes in Theranos TrialMore potentially damaging testimony against Elizabeth Holmes came on Friday in the Theranos fraud trial.
Kid-Size Doses Of Pfizer’s COVID-19 Vaccine More Than 90% EffectiveKid-size doses of Pfizer’s COVID-19 vaccine appear safe and nearly 91% effective at preventing symptomatic infections in 5- to 11-year-olds, according to study details released Friday as the U.S. considers opening vaccinations to that age group.
COVID: FDA Expected To Authorize Mixing Moderna, Johnson & Johnson Booster ShotsThe U.S. Food and Drug Administration is expected to authorize boosters for Moderna and Johnson & Johnson -- and perhaps even more anticipated for some -- allow for the mix-and-match of the vaccines.
COVID: Johnson & Johnson Reports Dramatic Boost To Immunity After Second DoseJohnson & Johnson announced Tuesday that booster shots given two months after the first dose increased protection against the virus to 94 percent- comparable to Pfizer and Moderna.
Pfizer Says COVID-19 Vaccine Works In Kids Ages 5 To 11; Will Seek FDA Approval There was good news Monday morning for San Francisco Bay Area parents worried about the safety of their children from COVID-19 in the classroom. Pfizer says its vaccine works for children ages 5 to 11 and will seek FDA approval to begin administering the shots.
FDA Advisers Endorse Pfizer Booster Shots for Elderly, High-Risk AmericansA panel of the Food and Drug Administration's vaccine advisers voted unanimously Friday in favor of an emergency use authorization for a third dose of Pfizer's COVID-19 vaccine, six months after some Americans completed their first two doses.
Health Officials Hope FDA's Full Approval Of Pfizer COVID Vaccine Will Convince HoldoutsBay Area public health officials are hoping the U.S. Food and Drug Administration's full approval of the Pfizer COVID vaccine will convince the hesitant and the holdouts to get their shot.